CanSino Biologics Inc
SSE:688185
CanSino Biologics Inc
SSE:688185
Price:
54.18
CNY
0.35%
Market Closed
Market Cap:
8.8B
CNY
Cash Flow Statement
Cash Flow Statement
CanSino Biologics Inc
CanSino Biologics Inc
Currency: CNY
Millions
TTM
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
(157)
|
0
|
0
|
0
|
(407)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
22
|
0
|
0
|
0
|
32
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
(27)
|
0
|
0
|
0
|
(24)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
0
|
0
|
7
|
7
|
0
|
61
|
85
|
157
|
162
|
140
|
103
|
75
|
77
|
39
|
47
|
110
|
106
|
140
|
138
|
36
|
19
|
|
| Cash Interest Paid |
9
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(9)
|
(200)
|
(176)
|
(174)
|
(70)
|
(630)
|
(853)
|
(1 171)
|
(1 045)
|
(1 272)
|
(1 335)
|
(1 161)
|
(990)
|
(866)
|
(826)
|
(899)
|
(953)
|
(910)
|
(840)
|
(919)
|
(739)
|
|
| Cash from Operating Activities |
(170)
N/A
|
(216)
-27%
|
(207)
+4%
|
(267)
-29%
|
(469)
-76%
|
(436)
+7%
|
411
N/A
|
946
+130%
|
2 050
+117%
|
1 464
-29%
|
68
-95%
|
(587)
N/A
|
(1 852)
-216%
|
(1 599)
+14%
|
(1 375)
+14%
|
(1 207)
+12%
|
(908)
+25%
|
(671)
+26%
|
(385)
+43%
|
(447)
-16%
|
(167)
+63%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(117)
|
(146)
|
(140)
|
(220)
|
(271)
|
(539)
|
(775)
|
(1 029)
|
(1 203)
|
(1 136)
|
(1 049)
|
(1 147)
|
(1 075)
|
(1 061)
|
(964)
|
(660)
|
(610)
|
(530)
|
(555)
|
(489)
|
(458)
|
|
| Other Items |
(681)
|
(688)
|
461
|
(3 204)
|
88
|
400
|
(1 750)
|
1 893
|
(1 357)
|
(2 327)
|
(942)
|
(1 104)
|
(153)
|
555
|
967
|
1 144
|
161
|
527
|
172
|
(405)
|
460
|
|
| Cash from Investing Activities |
(798)
N/A
|
(834)
-5%
|
321
N/A
|
(3 424)
N/A
|
(183)
+95%
|
(139)
+24%
|
(2 525)
-1 723%
|
863
N/A
|
(2 560)
N/A
|
(3 463)
-35%
|
(1 991)
+42%
|
(2 251)
-13%
|
(1 228)
+45%
|
(506)
+59%
|
4
N/A
|
484
+13 583%
|
(450)
N/A
|
(3)
+99%
|
(383)
-14 499%
|
(894)
-133%
|
2
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
1 128
|
0
|
0
|
0
|
4 984
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(7)
|
(17)
|
(16)
|
(26)
|
(40)
|
147
|
531
|
790
|
990
|
932
|
1 131
|
1 166
|
1 269
|
1 167
|
339
|
193
|
39
|
188
|
193
|
(48)
|
(260)
|
|
| Cash Paid for Dividends |
0
|
0
|
(4)
|
0
|
0
|
(5)
|
(5)
|
(5)
|
(14)
|
(20)
|
(27)
|
(234)
|
(241)
|
(257)
|
(264)
|
(74)
|
(74)
|
(67)
|
(68)
|
(65)
|
(64)
|
|
| Other |
(30)
|
(34)
|
(20)
|
4 947
|
(20)
|
38
|
581
|
(4 389)
|
578
|
436
|
(140)
|
(147)
|
(173)
|
(89)
|
(14)
|
(25)
|
27
|
30
|
(15)
|
3
|
(10)
|
|
| Cash from Financing Activities |
1 091
N/A
|
1 076
-1%
|
(40)
N/A
|
4 921
N/A
|
4 924
+0%
|
5 166
+5%
|
6 095
+18%
|
1 379
-77%
|
1 554
+13%
|
1 348
-13%
|
964
-28%
|
785
-19%
|
854
+9%
|
821
-4%
|
61
-93%
|
94
+54%
|
(8)
N/A
|
150
N/A
|
110
-27%
|
(109)
N/A
|
(334)
-206%
|
|
| Change in Cash | ||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
22
|
31
|
18
|
0
|
(27)
|
(28)
|
(35)
|
(7)
|
(34)
|
(54)
|
76
|
152
|
161
|
153
|
87
|
15
|
20
|
54
|
(4)
|
(32)
|
9
|
|
| Net Change in Cash |
145
N/A
|
58
-60%
|
92
+60%
|
1 231
+1 234%
|
4 244
+245%
|
4 563
+8%
|
3 946
-14%
|
3 181
-19%
|
1 009
-68%
|
(704)
N/A
|
(883)
-25%
|
(1 900)
-115%
|
(2 064)
-9%
|
(1 130)
+45%
|
(1 224)
-8%
|
(614)
+50%
|
(1 345)
-119%
|
(469)
+65%
|
(663)
-41%
|
(1 482)
-124%
|
(490)
+67%
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
(287)
N/A
|
(361)
-26%
|
(347)
+4%
|
(487)
-40%
|
(740)
-52%
|
(975)
-32%
|
(364)
+63%
|
(83)
+77%
|
847
N/A
|
328
-61%
|
(981)
N/A
|
(1 733)
-77%
|
(2 927)
-69%
|
(2 660)
+9%
|
(2 339)
+12%
|
(1 867)
+20%
|
(1 519)
+19%
|
(1 201)
+21%
|
(940)
+22%
|
(936)
+0%
|
(625)
+33%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
